glycine has been researched along with Anankastic Personality in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with glycine, an NMDAR coagonist, over 5 years led to robust reduction of OCD/BDD signs and symptoms except for partial relapses during treatment cessation." | 5.35 | High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. ( Challop, RS; Cleveland, WL; DeLaPaz, RL; Fawwaz, RA, 2009) |
| "Treatment with glycine, an NMDAR coagonist, over 5 years led to robust reduction of OCD/BDD signs and symptoms except for partial relapses during treatment cessation." | 1.35 | High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. ( Challop, RS; Cleveland, WL; DeLaPaz, RL; Fawwaz, RA, 2009) |
| "A sexually dimorphic pattern of genetic susceptibility to OCD may be present." | 1.32 | Gender in obsessive-compulsive disorder: clinical and genetic findings. ( Corfield, VA; Hemmings, SM; Kinnear, CJ; Knowles, JA; Lochner, C; Moolman-Smook, JC; Niehaus, DJ; Stein, DJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ade, KK | 1 |
| Wan, Y | 1 |
| Hamann, HC | 1 |
| O'Hare, JK | 1 |
| Guo, W | 1 |
| Quian, A | 1 |
| Kumar, S | 1 |
| Bhagat, S | 1 |
| Rodriguiz, RM | 1 |
| Wetsel, WC | 1 |
| Conn, PJ | 1 |
| Dzirasa, K | 1 |
| Huber, KM | 1 |
| Calakos, N | 1 |
| Shim, SS | 1 |
| Hammonds, MD | 1 |
| Vrabel, MM | 1 |
| Greenberg, WM | 1 |
| Benedict, MM | 1 |
| Doerfer, J | 1 |
| Perrin, M | 1 |
| Panek, L | 1 |
| Cleveland, WL | 2 |
| Javitt, DC | 1 |
| Bhattacharyya, S | 1 |
| Khanna, S | 1 |
| Chakrabarty, K | 1 |
| Mahadevan, A | 1 |
| Christopher, R | 1 |
| Shankar, SK | 1 |
| DeLaPaz, RL | 1 |
| Fawwaz, RA | 1 |
| Challop, RS | 1 |
| Camfield, DA | 1 |
| Sarris, J | 1 |
| Berk, M | 1 |
| Lochner, C | 1 |
| Hemmings, SM | 1 |
| Kinnear, CJ | 1 |
| Moolman-Smook, JC | 1 |
| Corfield, VA | 1 |
| Knowles, JA | 1 |
| Niehaus, DJ | 1 |
| Stein, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Adjunctive Glycine for Obsessive Compulsive Disorder[NCT00405535] | 24 participants (Actual) | Interventional | 2004-06-30 | Completed | |||
| Memantine for Refractory OCD Patients: a Pragmatic Double Blind, Randomized, Parallel Group, Placebo Controlled, Monocentric Trial[NCT05015595] | Phase 3 | 20 participants (Anticipated) | Interventional | 2021-09-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for glycine and Anankastic Personality
| Article | Year |
|---|---|
Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence.
Topics: 5-Hydroxytryptophan; Acetylcysteine; Dietary Supplements; Glycine; Humans; Hypericum; Inositol; Obse | 2011 |
1 trial available for glycine and Anankastic Personality
| Article | Year |
|---|---|
Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
Topics: Adult; Double-Blind Method; Female; Follow-Up Studies; Glycine; Humans; Male; Middle Aged; Obsessive | 2009 |
5 other studies available for glycine and Anankastic Personality
| Article | Year |
|---|---|
Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.
Topics: Animals; Behavior, Animal; Corpus Striatum; Excitatory Amino Acid Agonists; Excitatory Amino Acid An | 2016 |
D-cycloserine augmentation for behavioral therapy.
Topics: Antimetabolites; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Glycine; Huma | 2008 |
Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder.
Topics: Adult; Aged; Autoantibodies; Basal Ganglia; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; | 2009 |
High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.
Topics: Body Dysmorphic Disorders; Glycine; Glycine Agents; Humans; Male; Models, Neurological; Obsessive-Co | 2009 |
Gender in obsessive-compulsive disorder: clinical and genetic findings.
Topics: Adolescent; Adult; Age of Onset; Aged; Case-Control Studies; Comorbidity; Cysteine; Female; Gene Fre | 2004 |